OSLO,
Norway, May 31, 2023 /PRNewswire/ -- Following
Navamedic ASA's acquisition of Sensidose AB, the nomination
committee recommends that Åsa Kornfeld, previous Board member in
Sensidose AB, is elected as a new Navamedic ASA Board member in
addition to Terje Bakken (Chairman),
Narve Reiten, Jostein Davidsen, Annika Kollén and Edmée
Steenken on the Annual General Meeting on June 1st, 2023.
Åsa Kornfeld served as a Board member of Sensidose AB when
Navamedic ASA acquired the company. She is Pricing & Access
Lead in Recordati Rare Diseases based in Paris, and has extensive experience from the
pharmaceutical industry, with more than 25 years of international
experience. She holds an M.Sc Medicines and Healthcare products
from Université de Bordeaux, and
Finance for Executives from INSEAD.
On behalf of the nomination committee,
Bernt Olav Røttingsnes
For further information, please contact:
Kathrine G. Andreassen, CEO,
Navamedic, Mobile: +47 951 78 680 E-mail:
kathrine@navamedic.com
Lars Hjarrand, CFO, Navamedic, Mobile: +47 917 62 842 E-mail:
lars.hjarrand@navamedic.com
View original
content:https://www.prnewswire.co.uk/news-releases/updated-recommendation-by-the-nomination-committee-of-navamedic-asa-301838605.html